Vestor Capital’s CME Group CME Stock Holding History

Vestor Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.5M	Sell	59,212 -10,755	-15%	-$3.19M	1.27%	24
2025 Q4	$4.82M	Buy	69,967 +52,550	+302%	+$14.3M	0.33%	47
2025 Q3	$4.71M	Sell	17,417 -61,218	-78%	-$16.7M	0.3%	61
2025 Q2	$5M	Buy	78,635 +72,348	+1,151%	+$19.7M	0.37%	55
2025 Q1	$1.67M	Sell	6,287 -59	-0.9%	-$14.6K	0.14%	80
2024 Q4	$1.47M	Buy	6,346 +1,609	+34%	+$370K	0.11%	98
2024 Q3	$1.04M	Buy	4,737 +15	+0.3%	+$3.1K	0.08%	75
2024 Q2	$928K	Sell	4,722 -216	-4%	-$44.6K	0.07%	78
2024 Q1	$1.06M	Sell	4,938 -148	-3%	-$31.1K	0.09%	88
2023 Q4	$1.07M	Buy	5,086 +4,183	+463%	+$893K	0.1%	81
2023 Q3	$181K	Hold	903	–	–	0.02%	131
2023 Q2	$167K	Hold	903	–	–	0.02%	133
2023 Q1	$173K	Hold	903	–	–	0.02%	139
2022 Q4	$152K	Hold	903	–	–	0.02%	146
2022 Q3	$160K	Hold	903	–	–	0.02%	121
2022 Q2	$185K	Hold	903	–	–	0.02%	108
2022 Q1	$215K	Hold	903	–	–	0.02%	111
2021 Q4	$206K	Hold	903	–	–	0.02%	117
2021 Q3	$175K	Hold	903	–	–	0.02%	124
2021 Q2	$192K	Hold	903	–	–	0.02%	109
2021 Q1	$184K	Hold	903	–	–	0.02%	109
2020 Q4	$164K	Buy	+903	New	+$154K	0.02%	110
2020 Q1	$1.77M	Buy	+10,228	New	+$2.04M	0.35%	59

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vestor Capital's CME Position: Q1 2026 in Review

Vestor Capital reduced its CME Group (CME) stake by 15% in Q1 2026, selling an estimated $3.19M and leaving 59,212 shares worth $17.5M. The position accounts for 1.27% of the portfolio, ranked #24.

Vestor Capital first reported a position in CME in Q1 2020 and has held it in 23 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Vestor Capital held 59,212 shares of CME Group worth $17.5M as of Q1 2026.
Vestor Capital sold 10,755 CME Group shares in Q1 2026, an estimated $3.19M.
CME Group made up 1.27% of Vestor Capital's portfolio in Q1 2026, its #24 holding.
Vestor Capital first reported a position in CME Group in Q1 2020 and has held it in 23 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.